Evaluation of the Tissue Genesis® Icellator Cell Isolation System™ to Treat Critical Limb Ischemia

Clinical trial NCT02234778 · UNKNOWN

Trial details

NCT number: NCT02234778
Sponsor: Tissue Genesis
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2014-08-01
Primary completion: 2022-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.